Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
AN ORAL PHARMACEUTICAL FORMULATION COMPRISING SUSTAINED-RELEASE GRANULES CONTAINING TAMSULOSIN HYDROCHLORIDE
Document Type and Number:
WIPO Patent Application WO/2016/133333
Kind Code:
A2
Abstract:
An oral pharmaceutical formulation containing sustained-release granules including tamsulosin hydrochloride and a method of preparing the oral pharmaceutical formulation are provided. In the oral pharmaceutical formulation, the sustained-release granules includes about 10 parts to about 300 parts by weight of polyvinyl acetate, about 5 parts to about 250 parts by weight of hydroxypropyl methylcellulose, and about 1 part to about 450 parts by weight of a diluting agent with respect to 1 part by weight of tamsulosin hydrochloride, and a weight ratio of the sustained-release granules with respect to 1 part by weight of tamsulosin hydrochloride is about 360 to 495 parts by weight.

Inventors:
KIM HYUNG SEO (KR)
CHOI YOUNG KEUN (KR)
CHO JUNG HYUN (KR)
KIM JIN CHEUL (KR)
KIM YONG IL (KR)
PARK JAE HYUN (KR)
WOO JONG SOO (KR)
Application Number:
PCT/KR2016/001538
Publication Date:
August 25, 2016
Filing Date:
February 16, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HANMI PHARM IND CO LTD (KR)
International Classes:
A61K9/16; A61K9/00; A61K31/18; A61K47/38
Other References:
See references of EP 3242654A4
Attorney, Agent or Firm:
Y.P.LEE, MOCK & PARTNERS (13 Eonju-ro 30-gilGangnam-gu, Seoul, KR)
Download PDF: